„Rudolf Schindler“ award for our fusionVAC22_01 Study

Congratulations to Christopher Hackenbruch on receiving the „Rudolf Schindler“ abstract award at the Viszeralmedizin2023 meeting of the DGVS for our FusionVAC22_01 study, evaluating a peptide vaccine in combination with immune-checkpoint-inhibition for fibrolammelar hepatocellular carcinoma patients or other cancer entities carrying the DNAJB1-PRKACA fusion transcript. We are looking forward to start this trial at the CCU translational immunology and the Medical Department I together with Michael Bitzer supported by medizinische Fakultät, Else Kröner-Fresenius-Stiftung/ ForTra gGmbH and ROCHE Pharma AG.